New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
141
Total Open
Publications
101
Total
Citations
3.5K
Open Access
Percentage
72%
Total
Publications
141
Total Open
Publications
101
Total
Citations
3.5K
Breakdown
Publisher Open
9%
Both
40%
Other Platform Open
23%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 46%
32
Hybrid 41%
28
No Guarantees 13%
9
Other Platform Open
Domain 56%
50
Preprint 30%
27
Other Internet 29%
26
Institution 7%
6
Public 7%
6
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 48 |
Europe PMC | Domain | 18 |
Unknown Repository | Other Internet | 15 |
bioRxiv | Preprint | 15 |
Research Square | Preprint | 14 |
DOI | Other Internet | 8 |
Semantic Scholar | Public | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 4 |
University of Nottingham - Repository@Nottingham | Institution | 2 |
University of Birmingham - University of Birmingham Research Portal | Institution | 2 |